{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:26:45Z","timestamp":1789140405001,"version":"build-2803163510"},"reference-count":42,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Canadian Institutes of Health Research through the Canadian Research Initiative in Substance Misuse","award":["SMN-139150"],"award-info":[{"award-number":["SMN-139150"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,10,26]]},"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe opioid agonist treatment prescribing rates in provincial prisons and compare with community prescribing rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We used quarterly, cross-sectional data on the number and proportion of people prescribed opioid agonist treatment in prison populations. Trends were compared with Ontario surveillance data from prescribers, reported on a monthly basis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Provincial prisons and general population in Ontario, Canada between 2015 and 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults incarcerated in provincial prisons and people ages 15 years and older in Ontario.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcomes and measures<\/jats:title>\n                    <jats:p>Opioid agonist treatment prescribing prevalence, defined as treatment with methadone or buprenorphine\/naloxone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In prison, 6.9%\u20138.4% of people were prescribed methadone; 0.8% to 4.8% buprenorphine\/naloxone; and 8.2% to 13.2% either treatment over the study period. Between 2015 and 2018, methadone prescribing prevalence did not substantially change in prisons or in the general population. The prevalence rate of buprenorphine\/naloxone prescribing increased in prisons by 1.70 times per year (95%\u2009CI 1.47 to 1.96), which was significantly higher than the increase in community prescribing: 1.20 (95% CI 1.19 to 1.21). Buprenorphine\/naloxone prescribing prevalence was significantly different across prisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The increase in opioid agonist treatment prescribing between 2015 and 2018 in provincial prisons shows that efforts to scale up access to treatment in the context of the opioid overdose crisis have included people who experience incarceration in Ontario. Further work is needed to understand unmet need for treatment and treatment impacts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-048944","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T11:44:53Z","timestamp":1637235893000},"page":"e048944","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015\u20132018: a repeated cross-sectional analysis"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9560-1818","authenticated-orcid":false,"given":"Claire","family":"Bodkin","sequence":"first","affiliation":[{"name":"Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bondy","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonora","family":"Regenstreif","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Kiefer","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"Ontario Ministry of Community Safety and Correctional Services, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Kouyoumdjian","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"2025120619123332000_11.11.e048944.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157512","article-title":"Drug toxicity deaths after release from incarceration in Ontario, 2006-2013: review of coroner's cases","volume":"11","author":"Groot","year":"2016","journal-title":"PLoS One"},{"key":"2025120619123332000_11.11.e048944.2","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20150098"},{"key":"2025120619123332000_11.11.e048944.3","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-016-1935-4","article-title":"Access to primary care in adults in a provincial correctional facility in Ontario","volume":"9","author":"Green","year":"2016","journal-title":"BMC Res Notes"},{"key":"2025120619123332000_11.11.e048944.4","first-page":"215","article-title":"Health status of prisoners in Canada: narrative review","volume":"62","author":"Kouyoumdjian","year":"2016","journal-title":"Can Fam Physician"},{"key":"2025120619123332000_11.11.e048944.5","first-page":"S9","article-title":"A health care needs assessment of federal inmates in Canada","volume":"95","year":"2004","journal-title":"Can J Public Health"},{"key":"2025120619123332000_11.11.e048944.6","doi-asserted-by":"publisher","DOI":"10.1037\/a0033907"},{"key":"2025120619123332000_11.11.e048944.7","unstructured":"Mullins P , Farrell S . Offender substance use patterns-aboriginal and non-aboriginal offenders. Research Branch, Correctional Service Canada, 2012."},{"key":"2025120619123332000_11.11.e048944.8","unstructured":"Smith A , Cox K , Poon C , et al . Time out III: a profile of BC youth in custody. Vancouver, BC: McCreary Centre Society, 2013."},{"key":"2025120619123332000_11.11.e048944.9","unstructured":"Beaudette J . Prevalence of mental health disorders among incoming federal offenders. Atlantic, Ontario, & Pacific Regions: Research Branch, Correctional Service Canada, 2013."},{"key":"2025120619123332000_11.11.e048944.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201592","article-title":"The health care utilization of people in prison and after prison release: a population-based cohort study in Ontario, Canada","volume":"13","author":"Kouyoumdjian","year":"2018","journal-title":"PLoS One"},{"key":"2025120619123332000_11.11.e048944.11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14999013.2004.10471205","article-title":"Women inmates' mental health needs: evidence of the validity of the jail screening assessment tool (JSAT)","volume":"3","author":"Nicholls","year":"2004","journal-title":"Int J Forensic Ment Health"},{"key":"2025120619123332000_11.11.e048944.12","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.17269\/cjph.105.4193","article-title":"Drug use prior to incarceration and associated socio-behavioural factors among males in a provincial correctional facility in Ontario, Canada","volume":"105","author":"Kouyoumdjian","year":"2014","journal-title":"Can J Public Health"},{"key":"2025120619123332000_11.11.e048944.13","doi-asserted-by":"publisher","DOI":"10.1177\/0032885512457555"},{"key":"2025120619123332000_11.11.e048944.14","unstructured":"Zakaria D , Borgatta F , Jarvis A , et al . Summary of emerging findings from the 2007 national inmate infection diseases and risk-behaviours survey. Correctional Service of Canada, Research Branch, 2010."},{"key":"2025120619123332000_11.11.e048944.15","unstructured":"Kunic D , Grant BA . The computerized assessment of substance abuse (CASA): results from the demonstration project. Research Branch, Correctional Service of Canada, 2006."},{"key":"2025120619123332000_11.11.e048944.16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03403669","article-title":"Drug use and risk of bloodborne infections","volume":"96","author":"Martin","year":"2005","journal-title":"Can J Public Health"},{"key":"2025120619123332000_11.11.e048944.17","unstructured":"Grant BA , Varis DD , Lefebvre D . Intensive support units (ISU) for federal offenders with substance abuse problems: an impact analysis. Correctional Service Canada, 2005."},{"key":"2025120619123332000_11.11.e048944.18","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305379"},{"key":"2025120619123332000_11.11.e048944.19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00466.x"},{"key":"2025120619123332000_11.11.e048944.20","unstructured":"Johnson SL , Moser A , Cheverie M . Assessing the impact of enhanced drug interdiction activities at Kingston penitentiary: a pilot study. Correctional Service of Canada, Research Branch, 2011."},{"key":"2025120619123332000_11.11.e048944.21","unstructured":"Robinson D , Mirabelli L . Summary of findings of the 1995 CSC national inmate survey. Correctional Service Canada, Correctional Research & Development, 1996."},{"key":"2025120619123332000_11.11.e048944.22","first-page":"2","article-title":"Canada: study provides further evidence of risk of hepatitis C and HIV transmission in prisons","volume":"9","year":"2004","journal-title":"HIV AIDS Policy Law Rev"},{"key":"2025120619123332000_11.11.e048944.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02387.x"},{"key":"2025120619123332000_11.11.e048944.24","unstructured":"Farrell S , Ross J , Ternes M , et al . Prevalence of injection drug use among male offenders. Research Branch, Correctional Service Canada, 2010."},{"key":"2025120619123332000_11.11.e048944.25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF03405520","article-title":"Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia","volume":"100","author":"Buxton","year":"2009","journal-title":"Can J Public Health"},{"key":"2025120619123332000_11.11.e048944.26","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.2.113"},{"key":"2025120619123332000_11.11.e048944.27","doi-asserted-by":"publisher","DOI":"10.1177\/070674370605101002"},{"key":"2025120619123332000_11.11.e048944.28","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"key":"2025120619123332000_11.11.e048944.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"2025120619123332000_11.11.e048944.30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(16)30769-3","article-title":"Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners","volume":"388","author":"Kamarulzaman","year":"2016","journal-title":"Lancet"},{"key":"2025120619123332000_11.11.e048944.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03676.x"},{"key":"2025120619123332000_11.11.e048944.32","doi-asserted-by":"publisher","DOI":"10.1111\/add.13779"},{"key":"2025120619123332000_11.11.e048944.33","doi-asserted-by":"publisher","DOI":"10.1111\/add.12536"},{"key":"2025120619123332000_11.11.e048944.34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"2025120619123332000_11.11.e048944.35","doi-asserted-by":"crossref","unstructured":"Perry AE , Neilson M , Martyn\u2010St James M . Pharmacological interventions for drug\u2010using offenders. Cochrane Data Syst Rev 2015;6.","DOI":"10.1002\/14651858.CD010862.pub2"},{"key":"2025120619123332000_11.11.e048944.36","unstructured":"Assembly UNG . United nations standard minimum rules for the treatment of prisoners (the Nelson Mandela rules), 2015."},{"key":"2025120619123332000_11.11.e048944.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192431","article-title":"Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: a survey","volume":"13","author":"Kouyoumdjian","year":"2018","journal-title":"PLoS One"},{"key":"2025120619123332000_11.11.e048944.38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2018.09.003","article-title":"Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada","volume":"193","author":"Bozinoff","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"2025120619123332000_11.11.e048944.39","unstructured":"Ontario Prescription Opioid Tool . Ontario drug policy research network, 2020. Available: https:\/\/odprn.ca\/ontario-opioid-drug-observatory\/ontario-prescription-opioid-tool\/ [Accessed 1 Sep 2020]."},{"key":"2025120619123332000_11.11.e048944.40","unstructured":"Interactive Opioid Tool . Queen\u2019s printer for Ontario, 2020. Available: https:\/\/www.publichealthontario.ca\/en\/data-and-analysis\/substance-use\/interactive-opioid-tool"},{"key":"2025120619123332000_11.11.e048944.41","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00794","article-title":"Prevalence of opioid dependence and opioid agonist treatment in the Berlin Custodial setting: a cross-sectional study","volume":"11","author":"von Bernuth","year":"2020","journal-title":"Front Psychiatry"},{"key":"2025120619123332000_11.11.e048944.42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/add.14059","article-title":"Associations between methadone maintenance treatment and crime: a 17-year longitudinal cohort study of Canadian provincial offenders","volume":"113","author":"Russolillo","year":"2018","journal-title":"Addiction"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-048944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:12:41Z","timestamp":1765077161000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-048944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,18]]},"published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1136\/bmjopen-2021-048944"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-048944","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}